Vaccine accine acceptance or acceptance or refusal?: efusal?: Ind - - PowerPoint PPT Presentation

vaccine accine acceptance or acceptance or refusal efusal
SMART_READER_LITE
LIVE PREVIEW

Vaccine accine acceptance or acceptance or refusal?: efusal?: Ind - - PowerPoint PPT Presentation

Vaccine accine acceptance or acceptance or refusal?: efusal?: Ind Individu ividual al cho hoice ice vs vs so socie cieta tal l ne need eds or or My risks vs our risks Heidi J. Larson The Vaccine Confidence Project Faculty


slide-1
SLIDE 1

Vaccine accine acceptance or acceptance or refusal?: efusal?:

Ind Individu ividual al cho hoice ice vs vs so socie cieta tal l ne need eds

  • r
  • r

My risks vs “our” risks

Heidi J. Larson The Vaccine Confidence Project Faculty of Epidemiology and Population Health LSHTM

slide-2
SLIDE 2
slide-3
SLIDE 3

Risk as feelings

lings

(fast , instinctive, emotional.. ) Risk as analysis (logic, reason, scientific...) Risk as Po Poli litics tics

Adapted from Slovic et al. Risk Analysis 2004; 24 (2): 311-22

slide-4
SLIDE 4

So what do we need to do??

  • Scientists (and the Media!) must not to treat fear

and reservation as ignorance and then try to destroy them with a blunt “rational” instrument.

Pattison – BMJ 2001;323:838-840

slide-5
SLIDE 5

In the 19th Century

  • Principles were not well understood
  • Vaccination is ineffective.
  • Vaccination is not safe.
  • Religious and philosophical concerns.
  • Resistance to compulsory vaccination.

In the 21st Century

  • Principles STILL not well understood
  • Perception that vaccination is not needed
  • Concerns about vaccine safety
  • Religious and philosophical concerns
  • Resistance to compulsory vaccination

Reasons easons for

  • r vaccine hesitanc

vaccine hesitancy and opposition y and opposition

Heidi.larson@lshtm.ac.uk

slide-6
SLIDE 6

Vac accine cine he hesita sitanc ncy y an and d risk risk pe perce cept ption ion

heidi.larson@lshtm.ac.uk

slide-7
SLIDE 7

WHO Guidance

But what about the perception of safety??

slide-8
SLIDE 8

Prompters of questions and risk perceptions

  • Adverse Event (AEFI) –local AEFI are usually stronger

prompters of rumors, but a distant event reported can also spread and provoke questions

  • New research reported
  • New recommendation or policy change
  • New product (introduction of new product or product

packaging)

Larson/Restoring Public Trust

slide-9
SLIDE 9

http://www.gmofreeglobal.org/en/mission

Perceptions are also about motives

slide-10
SLIDE 10

Wo Worl rld Economic Forum: rum: Global Risk sks s 2013

Heidi.larson@lshtm.ac.uk

OPPORTUNITY or RISK?

The role of social media

slide-11
SLIDE 11

2013 Global Risks Report -World Economic Forum

Heidi.larson@lshtm.ac.uk

slide-12
SLIDE 12

Report of the Independent Monitoring Board of the Global Polio Eradication Initiative November 2012

Result of 2003-2004 rumour-driven vaccine boycott

Heidi.larson@lshtm.ac.uk

slide-13
SLIDE 13
slide-14
SLIDE 14
slide-15
SLIDE 15

Herd immunity or Herd mentality?

slide-16
SLIDE 16

Wakefield Lancet Article

slide-17
SLIDE 17

17

Determinants of vaccine hesitancy

Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review

  • f published literature, 2007-2012.

Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Vaccine. 2014 Apr 17;32(19):2150-2159.

slide-18
SLIDE 18

Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007-2012. Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Vaccine. 2014 Apr 17;32(19):2150-2159.

Articles about vaccine hesitancy by year and WHO region [n = 1164]

slide-19
SLIDE 19

Can we monitor public confidence in vaccines?

Heidi.larson@lshtm.ac.uk

slide-20
SLIDE 20

Heidi.larson@lshtm.ac.uk

slide-21
SLIDE 21

Tracking Anti-vaccination Sentiment in Eastern European Social Media Networks. UNICEF .2013

Influences on risk perceptions are highly varied

slide-22
SLIDE 22

Tracking Anti-vaccination Sentiment in Eastern European Social Media Networks. UNICEF .2013

Modes of communication differ by location

Heidi.larson@lshtm.ac.uk

slide-23
SLIDE 23

Perceptions of risk can have serious impacts

  • In the Philippines, risk perceptions that

tetanus vaccines caused sterilization led to a 45% drop in coverage between 1994 and 1995

  • In 1998, Andrew Wakefield’s publication linking MMR vaccine to bowel disease and

autism caused public confidence to plummet. MMR coverage rates in England dropped from nearly 93% in 1997 to 79.9% in 2003-04 due to risk perceptions

  • In Japan, adverse events following HPV vaccination, amplified by negative media and a

highly vocal victim support group led the government to withdraw their HPV recommendation (despite no evidence of vaccine-link) and HPV vaccine uptake plummeted from over 70% to under 10% between 2013-2014.

slide-24
SLIDE 24

Vaccine ine Risk Risk Perceptions an ions and Ad H Ad Hoc Ri Risk sk Co Commu mmunica ication: ion: An An E Empir mpirical ical Asse Assessmen ssmentDan M. Kahan

Although perceptions may seem to not have an immediate impact, they can have longer term impacts

slide-25
SLIDE 25
  • NAIROBI. MAY 2013 (25 years post-MMR Wakefield scare—risk perceptions travel)
slide-26
SLIDE 26
slide-27
SLIDE 27

heidi.larson@lshtm.ac.uk

The nature of vaccine concerns also vary Globally, by vaccine and over time

slide-28
SLIDE 28

heidi.larson@lshtm.ac.uk

slide-29
SLIDE 29

Larson, et al Measuring Vaccine Confidence Lancet ID . 2013

POSITIVE SENTIMENT REPORTS

Heidi.larson@lshtm.ac.uk

slide-30
SLIDE 30

NEGATIVE SENTIMENT REPORTS

Heidi.larson@lshtm.ac.uk

slide-31
SLIDE 31

Ne New w res esear earch s h sho hows ws tha that tr t trying to c ying to change hange ne nega gativ tive per e perceptions ceptions can mak can make things w e things wor

  • rse

se

slide-32
SLIDE 32

Source: Peter Sandman. http://www.psandman.com/articles/zurich.pdf

slide-33
SLIDE 33
slide-34
SLIDE 34

Culture Personal Beliefs Politics Society Scientific Evidence Media

TRUST

TRUST and RESPECT

can be the tipping point..

slide-35
SLIDE 35

Larson et al. Drug Safety 2012; 35(11)

Risk/benefit communication is only part of an

  • ngoing dynamic process…
slide-36
SLIDE 36

www.vaccineconfidence.org